Emergent BioSolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 34.28
    Last
  • 0.14  0.41%
    Today's Change
  • 34.14
    Previous Close
  • Today
     
    19.31
    36.20
    52 Week Low - High
8:04 pm ET 8/27/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding39 million
Market Cap$1 billion
Return on Equity ttm8.48%
Last DividendEBS:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.983
EPS: Year Est. 12/15 ttm1.450
 
EPS: Quarterly Actual 6/15 0.34
EPS: Quarterly Est. 9/15 0.55
 
Price/Earnings ttm34.88
Relative Price/Earnings--
Earnings Growth Rate13.95
Company Description
Emergent BioSolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
Revenue$450 million
Net Income$37 million
Total Assets$945 million
Employees1,280
Web Sitewww.emergentbiosolutions.com

Latest Headlines

Watchlist

Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now

 

Not Registered?

Get complete access to The Washington Post online - it's FREE!